Article
Deciphering the tumor-specific immunopeptidome <i>in vivo</i> with genetically engineered mouse models
2021-07-01
Abstract excerpt
Effective immunosurveillance of cancer requires the presentation of peptide antigens on major histocompatibility complex Class I (MHC-I). Recent developments in proteomics have improved the identification of peptides that are naturally presented by MHC-I, collectively known as the “immunopeptidome”. Current approaches to profile tumor immunopeptidomes have been limited to in vitro investigation, which fails to ca...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bda26777-d197-5425-aa16-ea2199214af4
- DOI
- 10.1101/2021.06.30.450516
